Consolidated Condensed Balance Sheets (USD $) In Millions, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Current Assets
Cash and cash equivalents	$ 3,888.0	$ 3,830.2
Short-term investments	1,324.4	1,567.1
Accounts receivable, net of allowances of $61.8 (2014) and $62.2 (2013)	3,002.9	3,434.4
Other receivables	743.2	588.4
Inventories	2,969.0	2,928.8
Prepaid expenses and other	1,111.8	755.8
Total current assets	13,039.3	13,104.7
Other Assets
Investments	7,204.8	7,624.9
Goodwill and other intangibles, net	4,203.1	4,331.1
Sundry	2,339.0	2,212.5
Total other assets	13,746.9	14,168.5
Property and Equipment
Land, buildings, equipment, and construction in progress	15,779.6	15,646.7
Accumulated depreciation	(7,808.9)	(7,671.2)
Property and equipment, net	7,970.7	7,975.5
Total assets	34,756.9	35,248.7
Current Liabilities
Short-term borrowings and current maturities of long-term debt	9.1	1,012.6
Accounts payable	1,149.9	1,119.3
Employee compensation	554.8	943.9
Sales rebates and discounts	1,724.2	1,941.7
Dividends payable	0	523.5
Income taxes payable	102.5	254.4
Deferred income taxes	760.4	792.8
Other current liabilities	2,330.8	2,328.4
Total current liabilities	6,631.7	8,916.6
Other Liabilities
Long-term debt	5,255.3	4,200.3
Accrued retirement benefits	1,553.1	1,549.4
Long-term income taxes payable	906.6	1,078.7
Other noncurrent liabilities	2,061.5	1,863.0
Total other liabilities	9,776.5	8,691.4
Shareholders' Equity
Common stock	700.1	698.5
Additional paid-in capital	5,034.6	5,050.0
Retained earnings	17,665.3	16,992.4
Employee benefit trust	(3,013.2)	(3,013.2)
Accumulated other comprehensive loss	(1,957.3)	(2,002.7)
Cost of common stock in treasury	(91.4)	(93.6)
Total Eli Lilly and Company shareholders' equity	18,338.1	17,631.4
Noncontrolling interests	10.6	9.3
Total equity	18,348.7	17,640.7
Total liabilities and equity	$ 34,756.9	$ 35,248.7